Bank Of New York Mellon Corp Taro Pharmaceutical Industries LTD Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$62.34 - $73.38 $672,149 - $791,183	-10,782 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$70.26 - $76.64 $26,558 - $28,969	-378 Reduced 3.39%	10,782 $0
Q1 2021 May 13, 2021	SELL	$70.48 - $79.95 $486,523 - $551,894	-6,903 Reduced 38.22%	11,160 $0
Q4 2020 Feb 09, 2021	BUY	$54.4 - $73.42 $127,404 - $171,949	2,342 Added 14.9%	18,063 $0
Q3 2020 Nov 12, 2020	SELL	$54.41 - $68.2 $1.02 Million - $1.28 Million	-18,714 Reduced 54.35%	15,721 $0
Q2 2020 Aug 12, 2020	SELL	$61.66 - $70.16 $46,923 - $53,391	-761 Reduced 2.16%	34,435 $0
Q1 2020 May 06, 2020	SELL	$59.35 - $88.73 $1.32 Million - $1.98 Million	-22,273 Reduced 38.76%	35,196 $0
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $669,029 - $883,140	9,019 Added 18.62%	57,469 $0
Q3 2019 Nov 07, 2019	SELL	$75.36 - $86.57 $109,950 - $126,305	-1,459 Reduced 2.92%	48,450 $0
Q2 2019 Aug 12, 2019	BUY	$83.92 - $108.88 $260,823 - $338,399	3,108 Added 6.64%	49,909 $4.26 Million
Q1 2019 May 14, 2019	SELL	$85.97 - $108.09 $895,377 - $1.13 Million	-10,415 Reduced 18.2%	46,801 $5.06 Million
Q4 2018 Feb 11, 2019	BUY	$78.25 - $107.92 $2.08 Million - $2.86 Million	26,540 Added 86.52%	57,216 $4.84 Million
Q3 2018 Nov 09, 2018	BUY	$97.82 - $116.09 $1.03 Million - $1.23 Million	10,567 Added 52.55%	30,676 $0
Q2 2018 Aug 06, 2018	BUY	$97.62 - $120.59 $828,989 - $1.02 Million	8,492 Added 73.1%	20,109 $2.33 Million
Q1 2018 May 15, 2018	BUY	$95.91 - $107.26 $546,111 - $610,738	5,694 Added 96.13%	11,617 $1.15 Million
Q4 2017 Feb 09, 2018	BUY	$104.5 - $126.38 $618,953 - $748,548	5,923	5,923 $620,000

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account